Literature DB >> 2375786

Logistic discriminant analysis of lipids and apolipoproteins in a population of coronary bypass patients and the significance of apolipoproteins C-III and E.

L Chivot1, F Mainard, E Bigot, J M Bard, J L Auget, Y Madec, J C Fruchart.   

Abstract

The lipid and apolipoprotein states of 74 men (mean age 49.96 +/- 5.9 years) were studied 24 h before coronary bypass surgery and their results were compared with those of a control group of 78 men (mean age 48.88 +/- 5.41 years). Apolipoproteins C-III (apo C-III) and E (apo E) were determined in particles with (LpB) and without (nonLpB) apo B separated using a concanavalin A reagent. Apo C-III was significantly increased in LpB particles (P less than 0.001), and apo E in LpB (P less than 0.001) and nonLpB (P less than 0.001) particles. The significant variables selected in logistic discriminant stepwise analysis were total cholesterol/HDL-cholesterol, apo E-nonLpB and apo C-III-LpB. This last parameter, which is more discriminant than triglycerides, provides a more specific indication of dyslipoproteinemia in coronary bypass patients; in association with the other two variables, it significantly improved the percentage of correctly classified individuals.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2375786     DOI: 10.1016/0021-9150(90)90042-h

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  8 in total

1.  Apolipoproteins E and CIII interact to regulate HDL metabolism and coronary heart disease risk.

Authors:  Allyson M Morton; Manja Koch; Carlos O Mendivil; Jeremy D Furtado; Anne Tjønneland; Kim Overvad; Liyun Wang; Majken K Jensen; Frank M Sacks
Journal:  JCI Insight       Date:  2018-02-22

2.  Comparative study of risk factors in patients undergoing coronary or femoropopliteal artery bypass grafting.

Authors:  F Mainard; J L Auget; P Vest; Y Madec
Journal:  Br Heart J       Date:  1994-12

3.  Effect of protein, unsaturated fat, and carbohydrate intakes on plasma apolipoprotein B and VLDL and LDL containing apolipoprotein C-III: results from the OmniHeart Trial.

Authors:  Jeremy D Furtado; Hannia Campos; Lawrence J Appel; Edgar R Miller; Nancy Laranjo; Vincent J Carey; Frank M Sacks
Journal:  Am J Clin Nutr       Date:  2008-06       Impact factor: 7.045

4.  Omega-3 Ethyl Ester Concentrate Decreases Total Apolipoprotein CIII and Increases Antithrombin III in Postmyocardial Infarction Patients.

Authors:  E Swahn; H von Schenck; A G Olsson
Journal:  Clin Drug Investig       Date:  1998       Impact factor: 2.859

5.  Antagonism between apolipoprotein AI regulatory protein 1, Ear3/COUP-TF, and hepatocyte nuclear factor 4 modulates apolipoprotein CIII gene expression in liver and intestinal cells.

Authors:  M Mietus-Snyder; F M Sladek; G S Ginsburg; C F Kuo; J A Ladias; J E Darnell; S K Karathanasis
Journal:  Mol Cell Biol       Date:  1992-04       Impact factor: 4.272

6.  Racial differences between African-American and white women in insulin resistance and visceral adiposity are associated with differences in apoCIII containing apoAI and apoB lipoproteins.

Authors:  Liyun Wang; Frank M Sacks; Jeremy D Furtado; Madia Ricks; Amber B Courville; Anne E Sumner
Journal:  Nutr Metab (Lond)       Date:  2014-12-17       Impact factor: 4.169

7.  Effect of milk fat on LDL cholesterol and other cardiovascular risk markers in healthy humans: the INNOVALAIT project.

Authors:  Jean-Marie Bard; Ludovic Drouet; Denis Lairon; Murielle Cazaubiel; Corinne Marmonier; Ewa Ninio; Claire Bal Dit Sollier; Jean-Charles Martin; Constance Boyer; Christine Bobin-Dubigeon
Journal:  Eur J Clin Nutr       Date:  2019-11-11       Impact factor: 4.016

8.  Effects of dietary saturated fat on LDL subclasses and apolipoprotein CIII in men.

Authors:  N Faghihnia; L M Mangravite; S Chiu; N Bergeron; R M Krauss
Journal:  Eur J Clin Nutr       Date:  2012-09-05       Impact factor: 4.016

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.